Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Methods and Findings in Experimental and Clinical Pharmacology|December 13, 2003
Irinotecan (CPT-11) in metastatic colorectal cancer patients resistant to 5-fluorouracil (5-FU): a phase II studyA Antón, E Aranda, A Carrato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2005
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancerC Camps, E Felip, J M Sanchez, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patientsE Díáz-Rubio, J Sastre, A Abad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2015
A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patientsE Van Cutsem, H Prenen, G D'Haens, et al.
Occupational and Environmental Medicine|October 24, 2007
Occupation and bladder cancer in a hospital-based case-control study in SpainC M Samanic, M Kogevinas, D T Silverman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2008
Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors StudyE Aranda, M Valladares, M Martinez-Villacampa, et al.
British Journal of Cancer|July 15, 2010
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapyE Martinez-Balibrea, A Abad, A Martínez-Cardús, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 6, 2013
Oncological translational research in the Spanish national health system: the INTRO studyC Caballero, E Jantus-Lewintre, A Carrato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM groupM Martin, A Villar, A Sole-Calvo, et al.
European Journal of Epidemiology|October 26, 2000
Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study GroupM Porta, S Costafreda, N Malats, et al.
Pageof 11